letrozole has been researched along with Adenomatous Polyposis Coli in 1 studies
Adenomatous Polyposis Coli: A polyposis syndrome due to an autosomal dominant mutation of the APC genes (GENES, APC) on CHROMOSOME 5. The syndrome is characterized by the development of hundreds of ADENOMATOUS POLYPS in the COLON and RECTUM of affected individuals by early adulthood.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Santti, K | 1 |
| Beule, A | 1 |
| Rönty, M | 1 |
| Ihalainen, H | 1 |
| Tarkkanen, M | 1 |
| Blomqvist, C | 1 |
1 other study available for letrozole and Adenomatous Polyposis Coli
| Article | Year |
|---|---|
The CDK 4/6 inhibitor ribociclib has activity in the treatment of inoperable desmoid tumor. A case report.
Topics: Abdominal Neoplasms; Adenomatous Polyposis Coli; Adult; Aminopyridines; Antineoplastic Combined Chem | 2019 |